These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26351443)

  • 1. Metastatic Prostatic Ductal Adenocarcinoma Successfully Treated with Docetaxel Chemotherapy: A Case Report.
    Fujiwara R; Kageyama S; Tomita K; Hanada E; Tsuru T; Yoshida T; Narita M; Isono T; Kawauchi A
    Case Rep Oncol; 2015; 8(2):339-44. PubMed ID: 26351443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
    Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M
    Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report.
    Kosaka T; Hongo H; Oya M
    BMC Cancer; 2019 Jun; 19(1):562. PubMed ID: 31185946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of ductal adenocarcinoma of the prostate treated with endocrine therapy and radiation therapy].
    Suzuki T; Shinbo H; Kurita Y; Furuse H; Mugiya S; Ozono S
    Hinyokika Kiyo; 2011 May; 57(5):261-4. PubMed ID: 21743285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COMPLETE RESPONSE OF BULKY LYMPH NODE METASTASES TREATED WITH ENZALUTAMIDE AFTER CHEMOTHERAPY WITH DOCETAXEL IN CASTRATION-RESISTANT PROSTATE CANCER: A CASE REPORT].
    Ishii T; Ide T; Miyajima T; Tominaga K; Miyajima S; Taira H; Haraoka S
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(3):201-205. PubMed ID: 32684582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report.
    Kitamura J; Taguchi S; Okegawa T; Honda K; Kii T; Tomida Y; Matsumoto R; Ninomiya N; Masuda K; Nakamura Y; Yamaguchi T; Kinjo M; Tambo M; Isomura A; Hayashi A; Kamma H; Higashihara E; Shibahara J; Fukuhara H
    BMC Med Genomics; 2021 Sep; 14(1):217. PubMed ID: 34479548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An 82-year-old Caucasian man with a ductal prostate adenocarcinoma with unusual cystoscopic appearance: a case report.
    Sfoungaristos S; Katafigiotis IS; Tyritzis SI; Kavouras A; Kanatas P; Petas A
    J Med Case Rep; 2011 Jan; 5():4. PubMed ID: 21223563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].
    Junca A; Frouin E; Irani J; Fromont G; Levillain P
    Ann Pathol; 2015 Dec; 35(6):496-501. PubMed ID: 26597142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal adenocarcinoma of the prostate with endometrioid features in a 69-year-old man.
    Cheng CJ; Chen KC; Chen WY; Su SJ
    J Formos Med Assoc; 2001 Oct; 100(10):707-11. PubMed ID: 11760379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
    Montgomery RB; Nelson PS; Lin D; Ryan CW; Garzotto M; Beer TM
    Cancer; 2007 Sep; 110(5):996-1002. PubMed ID: 17639587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of prostatic adenocarcinoma with ductal features].
    Yamashita R; Matsuzaki M; Matsui T; Yamaguchi R; Yuen K; Niwakawa M; Tobisu K
    Nihon Hinyokika Gakkai Zasshi; 2008 Mar; 99(3):525-30. PubMed ID: 18404881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of prostatic adenocarcinoma recurrence presenting as ductal carcinoma of the prostate.
    Tu WH; Jensen K; Freiha F; Liao JC
    Nat Clin Pract Urol; 2008 Jan; 5(1):55-8. PubMed ID: 18185514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
    Eastham JA; Kelly WK; Grossfeld GD; Small EJ;
    Urology; 2003 Dec; 62 Suppl 1():55-62. PubMed ID: 14747042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal adenocarcinoma of the prostate: immunohistochemical findings and clinical significance.
    Sha J; Bo J; Pan J; Zhang L; Xuan H; Chen W; Li D; Wang Z; Liu D; Huang Y
    Onco Targets Ther; 2013; 6():1501-6. PubMed ID: 24187500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two cases of mucinous adenocarcinoma of the prostate].
    Ishibashi Y; Kishida T; Yamaguchi T; Sugawara T; Satomi Y
    Hinyokika Kiyo; 1992 Apr; 38(4):463-7. PubMed ID: 1326881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of a prospective, Phase II study of long-term androgen ablation, pelvic radiotherapy, brachytherapy boost, and adjuvant docetaxel in patients with high-risk prostate cancer.
    Dibiase SJ; Hussain A; Kataria R; Amin P; Bassi S; Dawson N; Kwok Y
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):732-6. PubMed ID: 21036486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: preliminary results.
    Hussain A; Dawson N; Amin P; Naslund M; Engstrom C; Chen T
    Semin Oncol; 2001 Aug; 28(4 Suppl 15):22-31. PubMed ID: 11685725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
    Slovin SF
    Nat Clin Pract Oncol; 2007 Sep; 4(9):551-4. PubMed ID: 17728713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.